Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L

Considering the increasing number of identified driver oncogene alterations, additional genetic tests are required to determine the treatment for advanced non‐small‐cell lung cancer (NSCLC). Next‐generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer science 2022-01, Vol.113 (1), p.221-228
Hauptverfasser:	Sakata, Shinya, Otsubo, Kohei, Yoshida, Hisako, Ito, Kentaro, Nakamura, Atsushi, Teraoka, Shunsuke, Matsumoto, Naohisa, Shiraishi, Yoshimasa, Haratani, Koji, Tamiya, Motohiro, Ikeda, Satoshi, Miura, Satoru, Tanizaki, Junko, Omori, Shota, Yoshioka, Hiroshige, Hata, Akito, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Anaplastic Lymphoma Kinase - genetics Biopsy Carcinoma, Non-Small-Cell Lung - genetics Carcinoma, Non-Small-Cell Lung - surgery Dissection ErbB Receptors - genetics Female Genes Genetic screening Genetic Testing - methods High-Throughput Nucleotide Sequencing Humans Kinases Laboratories Lung cancer Lung Neoplasms - genetics Lung Neoplasms - surgery Male Middle Aged Multivariate Analysis Mutation next‐generation sequencing gene panel Non-small cell lung carcinoma non‐small‐cell lung cancer Oncomine Dx Original Patients Prognosis Protein-Tyrosine Kinases - genetics Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins B-raf - genetics Retrospective Studies Sequence Analysis, DNA Success Treatment Outcome turnaround time
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!